Porth's Essentials of Pathophysiology, 4e

156

Cell and Tissue Function

U N I T 1

R E F E R E N C E S

25. Ceschi M, Gutzwiller F, Mody H, et al. Epidemiology and pathophysiology of obesity as a cause of cancer. Swiss Med Wkly . 2007;137:50–56. 26. Finn OJ. Cancer immunology. N Engl J Med. 2008;358(25): 2704–2715. 27. Burnett FM. Immunologic aspects of malignant disease. Lancet 1967;1:1171. 28. Michels KB, Willett WC. Etiology of cancer: dietary factors. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology . 9th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2011:217–226. 29. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer . 2007;7:599–612. 30. Jablon S, Kato H. Studies of the mortality of A-bomb survivors: 5. Radiation dose and mortality, 1950–1970. Radiat Res . 1972;50:649–698. 31. Liao JB. Viruses and human cancer. Yale J Biol Med . 2006;79: 115–122. 32. Centers for Disease Control and Prevention. HPV vaccine information for young women—Fact sheet . [Online]. Available at: http://www.cdc.gov/std/hpv/STDFact-HPV-vaccine-young- women.htm. Accessed September 26, 2013. 33. Cornett PA, Dea TO. Cancer. In: Papadakis MA, McPhee SJ, eds. Current Medical Diagnosis and Treatment . 52th ed. New York, NY: McGraw-Hill; 2013:1593–1663. 34. Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 2004;116(7A):11S–26S. 35. Hurter B, Bush NJ. Cancer-related anemia: Clinical review and management update. Clin J Oncol Nurs. 2007;11(3):349–359. 36. Dicato M, Plawny L, Diederich M. Anemia in cancer. Ann Oncol. 2011;27(7):viii,167–172. 37. Pedrazzoli P, Rosti G, Secondino S, et al. Iron supplementation and erythropoiesis-stimulatory agents in the treatment of cancer anemia. Cancer . 2009;115:1169–1175. 38. Gordon JN, Green SR, Goggin PM. Cancer cachexia. Q J Med . 2005;98:779–788. 39. Tisdale MJ. Molecular pathways leading to cancer cachexia. Physiology (Bethesda). 2005;20:340–348. 40. Bennani-Baita N, Davis MP. Cytokines and cancer anorexia cachexia syndrome. Am J Hosp Palliat Care. 2008;25(5):407–441. 41. Wu H, Davis JE, Natavio T. Fatigue and distrupted sleep-wake patterns in patients with cancer: A shared mechanism. Clin J Oncol Nurs. 2012;16(2):E56–E68. 42. Ryan JL, Carroll JK, Ryan EP, et al. Mechanisms of cancer- related fatigue. Oncologist. 2007;12(Suppl 1):S1–S22. 43. Wang XS. Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs. 2008;12(5 Suppl 1):11–20. 44. Hofman M, Ryan JL, Comar D, et al. Cancer-related fatigue: the scale of the problem. Oncologist. 2007;12(Suppl 1):4–10. 45. Barsevick AM, Newhall T, Brown S. Management of cancer- related fatigue. Clin J Oncol Nurs. 2008;12(5 Suppl 1):21–25. 46. Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2012;85(9): 838–854. 47. Boyiadzis M, Lieberman FS, Geskin LJ, et al. Paraneoplastic syndromes. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology . 9th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2011:2220–2238. 48. Dalmau J, Rosenfeld M. Paraneoplastic neurologic syndromes. In: Abeloff MD, Armitage JO, Niolerhuber JE, et al. Clinical Oncology . 4th ed. London, UK: Elsevier/Churchill Livingston; 2008:767–779. 49. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543–1554.

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin . 2013;63:71–81. 2. Striker TP, Kumanr V. Neoplasia. In: Kumar V, Abbas A, Fausto N, et al. Robbins and Cotran Pathologic Basis of Disease . 8th ed. Philadelphia, PA: Saunders Elsevier; 2010:259–330. 3. Strayer DS, Rubin E, et al. Neoplasia. In: Rubin R, Strayer DS, eds. Rubin’s Pathology: Clinicopathologic Foundations of Medicine . 6th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2012:157–212. 4. Janssen A, Medema RH. Genetic instability: tipping the balance. Oncogene . 2013;32:4459–4470. 5. Alberts B, Johnson A, Lewis J, et al. The Cell . 5th ed. New York, NY: Garland Science; 2008:1133–1139, 1175–1176, 1230–1240. 6. Wang L. Molecular signaling regulating anchorage-independence growth in cancer cells. Mt Sinai J Med. 2004;71(6):361–367. 7. Carruba G, Webber MM, Quader STA, et al. Regulation of cell- to-cell communication in non-tumorigenic and malignant human prostate epithelial cells. Prostate . 2002;50:73–82. 8. Marutsuka T, Shimada S, Shiomori K, et al. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intra peritoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res . 2003;9:678–685. 9. Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis—Impact on cancer metastasis. J Leukoc Biol . 2006;8:691–696. 11. Minn AJ, Massagu è J. Molecular biology of cancer: invasion and metastasis. In: DeVita VT Jr., Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology . 9th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2011:113–126. 12. Kerbel RS. Angiogenesis. N Engl J Med . 2008;358:2039–2049. 13. Harlozinska A. Progress in molecular mechanisms of tumor metastasis and angiogenesis. Anticancer Res . 2005;25:3327–3334. 14. Ruffini PA, Morandi P, Altundag K, et al. Manipulating the chemokine-chemokine receptor network to treat cancer. Cancer. 2007;109(12):2392–2404. 15. Kakinuma T, Twang ST. Chemokines, chemokine receptors, and 17. Zhou BP, Hung MC. Dysregulation of cellular signaling by HER2/neu in breast cancer. Semin Oncol. 2003;30(5 Suppl 16): 38–48. 18. Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11): 1148–1159. 19. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol . 2005;2:S4–S11. 20. Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis. 2012;33(6):1126–1133. 21. Schulze-Bergkamen H, Krammer PH. Apoptosis in cancer— Implications for therapy. Semin Oncol . 2004;31:90–119. 22. Mooi WJ, Peeper DS. Oncogene-induced cell senescence— Halting the road to cancer. N Engl J Med. 2006;355(10): 1037–1046. 23. Kerbel RS. Tumor angiogenesis. N Engl J Med. 2008;358(19): 2039. 24. Boccaccio C, Comoglio PM. Invasive growth: a MET -driven genetic programme for cancer and stem cells. Nat Rev Cancer . 2006;6:637–645. 10. Chen SL, Iddings DM, Scheri R, et al. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin . 2006;56:292–307. cancer metastasis. J Leukoc Biol . 2006;79:639–651. 16. Crocce CM. Oncogenes and cancer. N Engl J Med. 2008;358(5):502–511.